Total Payments
$10,578
2024 Payments
$1,478
Companies
34
Transactions
270
Medicare Patients
9,286
Medicare Billing
$683,084
Payment Breakdown by Category
Food & Beverage$7,493 (70.8%)
Travel$3,061 (28.9%)
Education$24.68 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,493 | 258 | 70.8% |
| Travel and Lodging | $3,061 | 11 | 28.9% |
| Education | $24.68 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $2,121 | 23 | $0 (2024) |
| Boston Scientific Corporation | $1,769 | 16 | $0 (2024) |
| ABIOMED | $991.17 | 13 | $0 (2023) |
| Corindus Inc. | $908.12 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $658.71 | 31 | $0 (2024) |
| Amgen Inc. | $370.77 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $325.03 | 17 | $0 (2024) |
| PFIZER INC. | $307.25 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $304.12 | 18 | $0 (2024) |
| Cardiovascular Systems Inc. | $291.77 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,478 | 71 | Novartis Pharmaceuticals Corporation ($226.77) |
| 2023 | $1,456 | 61 | Novartis Pharmaceuticals Corporation ($208.54) |
| 2022 | $1,443 | 70 | Novartis Pharmaceuticals Corporation ($223.40) |
| 2021 | $343.08 | 15 | ABIOMED ($177.01) |
| 2020 | $220.47 | 7 | Boston Scientific Corporation ($96.93) |
| 2019 | $4,264 | 34 | Abbott Laboratories ($1,766) |
| 2018 | $1,195 | 9 | Corindus Inc. ($908.12) |
| 2017 | $177.51 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($96.72) |
All Payment Transactions
270 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Vascular | ||||||
| 12/26/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Vascular | ||||||
| 12/26/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Vascular | ||||||
| 12/26/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Vascular | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.24 | General |
| Category: Cardiovascular | ||||||
| 11/27/2024 | Acist Medical Systems, Inc. | CVI Systems (Device) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Diagnostic Imaging | ||||||
| 11/25/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: AVVIGO_IC | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.40 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: Cardiovascular | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Cardiovascular | ||||||
| 11/01/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $43.70 | General |
| Category: AVVIGO_IC | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Genetic Disease | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: DIABETES | ||||||
| 10/18/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.29 | General |
| Category: Cardiovascular | ||||||
| 09/06/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.36 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 3,513 | 4,506 | $1.0M | $230,423 |
| 2022 | 38 | 3,285 | 4,427 | $1.1M | $266,674 |
| 2021 | 32 | 1,891 | 2,352 | $502,259 | $148,654 |
| 2020 | 11 | 597 | 698 | $114,187 | $37,333 |
Total Patients
9,286
Total Services
11,983
Medicare Billing
$683,084
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 386 | 793 | $273,585 | $79,942 | 29.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 182 | 187 | $105,842 | $30,153 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 124 | 124 | $55,428 | $15,729 | 28.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 154 | $40,964 | $15,277 | 37.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 23 | 30 | $45,000 | $12,679 | 28.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 215 | 220 | $86,900 | $12,086 | 13.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 55 | 55 | $37,270 | $10,636 | 28.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,307 | 1,640 | $36,080 | $10,237 | 28.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 44 | $22,616 | $5,991 | 26.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 26 | 26 | $67,210 | $5,186 | 7.7% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 147 | 152 | $16,416 | $5,139 | 31.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 32 | 38 | $27,675 | $3,370 | 12.2% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 23 | 24 | $50,880 | $3,058 | 6.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 16 | 64 | $32,768 | $2,663 | 8.1% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 16 | 32 | $7,104 | $2,368 | 33.3% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 29 | 30 | $20,625 | $2,281 | 11.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 150 | 156 | $6,084 | $1,785 | 29.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 29 | 29 | $5,713 | $1,559 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $4,228 | $1,291 | 30.5% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 24 | 30 | $2,580 | $1,154 | 44.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 74 | 90 | $1,170 | $756.00 | 64.6% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 11 | 11 | $2,486 | $692.71 | 27.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 37 | 37 | $2,590 | $692.48 | 26.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 45 | 52 | $2,236 | $682.24 | 30.5% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 11 | 11 | $6,188 | $640.53 | 10.4% |
About Dr. David Suk, MD
Dr. David Suk, MD is a Cardiovascular Disease healthcare provider based in Anaheim, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2009. The National Provider Identifier (NPI) number assigned to this provider is 1083841720.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Suk, MD has received a total of $10,578 in payments from pharmaceutical and medical device companies, with $1,478 received in 2024. These payments were reported across 270 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,493).
As a Medicare-enrolled provider, Suk has provided services to 9,286 Medicare beneficiaries, totaling 11,983 services with total Medicare billing of $683,084. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Anaheim, CA
- Active Since 06/21/2009
- Last Updated 11/11/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1083841720
Products in Payments
- Xience V coronary stent system (Device) $1,236
- Impella (Device) $991.17
- ROTABLATOR (Device) $727.91
- GENERAL VASCULAR ACCESS (Device) $707.69
- LEQVIO (Drug) $598.89
- Xience Sierra Coronary Stent System (Device) $497.24
- Repatha (Biological) $347.38
- ELIQUIS (Drug) $279.06
- Arcalyst (Drug) $278.33
- JARDIANCE (Drug) $277.02
- LifeVest (Device) $269.44
- FARXIGA (Drug) $227.71
- CAMZYOS (Drug) $223.97
- Coronary Orbital Atherectomy System (Device) $213.94
- VERQUVO (Drug) $198.26
- VYNDAQEL (Drug) $187.19
- XARELTO (Drug) $177.55
- ONPATTRO (Drug) $140.65
- AMVUTTRA (Drug) $134.38
- WATCHMAN (Device) $114.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Anaheim
Raveen Arora, M.d, M.D
Cardiovascular Disease — Payments: $151,294
Cardiovascular Disease $151,294
Mr. Narayanaiyengar Devaraj, Md, MD
Cardiovascular Disease — Payments: $13,887
Cardiovascular Disease $13,887
Ameesh Parikh, M.d, M.D
Cardiovascular Disease — Payments: $5,378
Cardiovascular Disease $5,378
David Kramer, M.d, M.D
Cardiovascular Disease — Payments: $3,482
Cardiovascular Disease $3,482
Dr. Prasanna Challa, M.d, M.D
Cardiovascular Disease — Payments: $1,845
Cardiovascular Disease $1,845
Ravi Jandhyala, Md, MD
Cardiovascular Disease — Payments: $1,831
Cardiovascular Disease $1,831